Innate and Acquired Resistance to Anti-EGFR Therapy-Letter.

I read with great interest the recent article by Parseghian and colleagues ([1][1]), presenting a review of the mechanisms underlying the innate and acquired resistance to anti-EGFR therapy. This “in-depth review” of the resistance mechanisms, however, does not include the possible host antibody